Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1500 | AZD5363 | 10.0 | 8.0664 | -0.20228 |
| HCC1500 | AZD5363 | 0.316227766017 | 4.3646 | -0.24185 |
| HCC1500 | RO-3306 | 0.0316227766017 | 4.1371 | -0.18568 |
| HCC1500 | Ulixertinib | 0.001 | 3.9179 | -0.16144 |
| HCC1428 | AZD6738 | 0.316227766 | 3.7356 | -0.02921 |
| HCC1500 | Alvocidib | 0.0316227766017 | 3.6246 | -0.22656 |
| HCC1500 | THZ531 | 0.001 | 3.5036 | -0.16745 |
| HCC1500 | THZ1 | 0.0001 | 3.4245 | -0.19370 |
| HCC1500 | SHP099 | 0.001 | 3.3854 | -0.19873 |
| HCC1500 | AZD5363 | 0.00316227766017 | 3.3080 | -0.18297 |
| HCC1500 | AZD5363 | 10.0 | 3.2698 | -0.24139 |
| HCC1500 | Alvocidib | 0.000316227766017 | 3.2698 | -0.21698 |
| HCC1500 | AZD5363 | 3.16227766017 | 3.0464 | -0.20162 |
| HCC1500 | AZD5363 | 0.0316227766017 | 2.6298 | -0.18204 |
| HCC1428 | SHP099 | 0.1 | 2.6271 | -0.02290 |
| HCC1428 | AZD5363 | 0.031622777 | 2.5940 | -0.03545 |
| HCC1500 | THZ1 | 0.01 | 2.5641 | -0.17739 |
| HCC1428 | AZD6738 | 0.031622777 | 2.5068 | -0.00830 |
| HCC1500 | Ribociclib | 0.01 | 2.4674 | -0.16837 |
| HCC1500 | SHP099 | 1.0 | 2.4357 | -0.15177 |
| HCC1428 | AZD6738 | 3.16227766 | 2.3998 | -0.00523 |
| HCC1428 | AZD5363 | 0.001 | 2.3576 | -0.02682 |
| HCC1428 | Ulixertinib | 0.031622777 | 2.3367 | -0.01989 |
| HCC1500 | THZ531 | 0.000316227766017 | 2.3113 | -0.19337 |
| HCC1500 | Alvocidib | 0.00316227766017 | 2.3113 | -0.16071 |